3-Cyclopentylacrylonitrile: A Key Pharmaceutical Intermediate for Ruxolitinib and Trasitinib Phosphate Synthesis

Discover the critical role of 3-Cyclopentylacrylonitrile in advanced pharmaceutical synthesis, vital for developing cutting-edge oncology treatments.

Get a Quote & Sample

Key Advantages

Versatile Synthetic Utility

Leverage 3-Cyclopentylacrylonitrile's reactivity for diverse organic synthesis applications, enabling the creation of complex molecular architectures.

Crucial for Targeted Therapies

This compound is foundational for the synthesis of Ruxolitinib, a JAK inhibitor crucial for treating myeloproliferative neoplasms, showcasing its role in innovative cancer treatments.

Enables Green Chemistry Practices

Investigate how green chemistry solvent selection and continuous flow synthesis for intermediates contribute to more sustainable and efficient manufacturing processes.

Key Applications

Pharmaceutical Synthesis

3-Cyclopentylacrylonitrile serves as a critical intermediate in the multi-step synthesis of Ruxolitinib and Trasitinib phosphate, contributing to advanced cancer therapies.

Organic Building Blocks

Its unique structure and reactivity make it a valuable building block for chemists engaged in complex organic synthesis and the development of novel compounds.

Drug Discovery Research

Researchers utilize this compound in exploring new synthetic routes and developing improved methodologies for API production, advancing drug discovery.

Process Optimization

The study of its synthesis methods, such as the Horner-Wadsworth-Emmons reaction, aids in process optimization for manufacturing high-purity pharmaceutical intermediates.